News >

Blood-Based Markers Key to Precision Medicine Approach in Breast Cancer

Brandon Scalea
Published: Tuesday, Jul 09, 2019

Mark Burkard, MD, PhD

Mark Burkard, MD, PhD

Blood-based markers are the key to better understanding the biology of various breast cancer subtypes, said Mark E. Burkard, MD, PhD.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Advancing the Treatment of Bladder Cancers Using Evidence-Based Immuno-Oncology StrategiesJul 30, 20191.0
Medical Crossfire®: Where Are We Headed in the Treatment of Triple-Negative Breast Cancer?Jul 31, 20191.5
Publication Bottom Border
Border Publication